All In Biotech

Drug Trial Radar · NCT06294990

Klinefelter Syndrome and Testosterone Treatment in Puberty

Klinefelter Syndrome - the Effect of Testosterone Treatment in Puberty. a Randomized, Double-blind Placebo-controlled Intervention Study: 'The TiPY Study'

Last checked: Nov 20, 2026Latest source record: Feb 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

32

Planned (sponsor's estimate)

Start

Aug 15, 2024

Primary completion

Dec 31, 2029

Study completion Dec 31, 2029

Sponsor

Lead sponsor
Lise AksglædeAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 6, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 10 years, up to 14 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this randomized clinical trial is to study the effect of testosterone replacement therapy during puberty in boys with Klinefelter syndrome (KS, 47,XXY). The main questions to answer are how treatment with testosterone will affect body fat mass, lipid and glucose metabolism, growth and body proportions, bone mineralization as well as effects on neurocognitive development and emotional and social difficulties. Participants will be randomized to two years treatment with testosterone or placebo.

Conditions

  • Klinefelter Syndrome

Interventions

  • Testosterone gelDrug

    Two years treatment with testosterone

  • PlaceboOther

    Two years treatment with placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes in body fat massTime frame: Baseline and 1 and two years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Copenhagen University Hospital, Rigshospitalet

    Copenhagen, Denmark · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.